Skip to main content
. 2016 Oct 5;36(1):35–43. doi: 10.1007/s10067-016-3424-5

Table 4.

Association of bDMARD therapy duration and DAS28 scores

Treatment duration (months) Patientsa (n = 412) Mean score (SD) p value
0.0–2.9 312 4.6 (1.5)
3.0–5.9 35 3.5 (1.4) 0.0002*
6.0–11.9 25 3.9 (1.4) 0.0945*
>12 40 3.2 (1.4) <0.0001*

*Compared with 0.0–2.9-month group, with analysis of variance followed by Bonferroni correction. The adjusted α = 0.05/6 = 0.0083; *p < 0.0083

aNumber of patients with available score data